<document xmlns="http://cnx.rice.edu/cnxml">
  <title>Otic Anti-inflammatories and Anti-infectives</title>
  <metadata xmlns:md="http://cnx.rice.edu/mdml">
    <md:title>Otic Anti-inflammatories and Anti-infectives</md:title>
    <md:content-id>m00466</md:content-id>
    <md:uuid>f73fa4fb-c413-4171-9f1f-7b3f5dadb675</md:uuid>
  </metadata>
<content>
<section class="learning-objectives" id="sect-00001">
<title>Learning Outcomes</title>
<para id="para-00001">By the end of this section, you should be able to:</para>
<list id="list-00001">
<item>Identify the characteristics of anti-inflammatory and anti-infective drugs used to treat ear disorders.</item>
<item>Explain the indications, actions, adverse reactions, and interactions of anti-inflammatory and anti-infective drugs used to treat ear disorders.</item>
<item>Describe nursing implications of anti-inflammatory and anti-infective drugs used to treat ear disorders.</item>
<item>Explain the client education related to anti-inflammatory and anti-infective drugs used to treat ear disorders.</item>
</list>
</section>
<section id="sect-00003">
<title>Otic Anti-Inflammatories</title>
<para id="para-00002"><term class="no-emphasis" id="term-00001">Anti-inflammatory drugs</term> block substances in the body that cause inflammation. Otic anti-inflammatories are used for the treatment of superficial bacterial infections of the external auditory canal (i.e., otitis externa) caused by susceptible organisms. Anti-inflammatory medications frequently are administered in combination with antibiotics. A treatment response should occur within 48 to 72 hours, otherwise the provider should reassess (Medina-Blasini &amp; Sharman, 2023).</para>
<section id="sect-00004">
<title>Adverse Effects and Contraindications</title>
<para id="para-00003">Adverse effects are rare; however, clients can experience allergic reactions characterized by rash, itching, and redness. Dizziness may occur. Prolonged usage can result in a superinfection that requires additional medications to resolve.</para>
<para id="para-00004"><link target-id="table-00001" document="m00466"/> is a drug prototype table for <term class="no-emphasis" id="term-00002">otic anti-inflammatories</term> featuring <term class="no-emphasis" id="term-00003">neomycin and polymyxin B sulfates, and hydrocortisone otic solution</term> (<term class="no-emphasis" id="term-00004">Cortisporin</term>). It lists drug class, mechanism of action, adult and <term class="no-emphasis" id="term-00005">pediatric dosage</term>, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
<table class="vertically-tight" id="table-00001">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Class</emphasis></span><newline/>
Antibacterial and anti-inflammatory<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline/>
Suppresses the inflammatory response (hydrocortisone)<newline/>
Works against susceptible organisms (anti-infectives)</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline/>
<emphasis effect="italics">Adults:</emphasis> 4 drops of medication instilled in the ear 3–4 times daily, not to exceed 10 days.<newline/>
<emphasis effect="italics">Children:</emphasis> 3 drops of medication instilled in the ear 3–4 times daily, not to exceed 10 days.<newline/>
Each mL contains: neomycin sulfate 3.5 mg, polymyxin B 10,000 units, and hydrocortisone 10 mg (1%).</entry>
</row>
<row><entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Indications</span></emphasis><newline/>
For the treatment of superficial bacterial infections of the external auditory canal (i.e., otitis externa) caused by susceptible organisms<newline/>
For the treatment of infections of mastoidectomy<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline/>
Reduces ear pain<newline/>
Reduces bacterial infection<newline/>
Decreases inflammation</entry>
<entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Drug Interactions</span></emphasis><newline/>
No significant interactions<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline/>
No significant interactions</entry>
</row>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
Local, adverse reactions (most common are burning, itching, irritation, and dryness)<newline/>
Stinging and burning (if medication reaches the middle ear)<newline/>
Hearing loss (with prolonged use—treatment should be limited to 10 days)</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline/>
Perforated eardrum<newline/>
Fungal or viral lesions<newline/>
Hypersensitivity to any medication components</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Prototype Table: Neomycin and Polymyxin B Sulfates, and Hydrocortisone Otic Solution</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
</section>
<section id="sect-00005">
<title>Nursing Implications</title>
<para id="para-00005">The nurse should do the following for clients who are taking otic anti-inflammatories:</para>
<list list-type="bulleted" id="list-00002">
<item>Recognize and monitor for serious and other potential side effects. Rarely, anaphylaxis can occur with the first dose.
<list list-type="bulleted" id="list-00003">
<item>Clients with latex allergies may need to use an alternative (latex-free) dropper for administration.</item></list></item>
<item>Perform hand hygiene before administering otic anti-inflammatory medication.</item>
<item>Educate the client on ear position and time to remain in a lying position after instillation.</item>
<item>Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.</item>
</list>
<note class="client-teaching" id="note-00001">
<para id="para-00006"><emphasis effect="bold">The client taking an otic anti-inflammatory should:</emphasis></para>
<list list-type="bulleted" id="list-00004">
<item>If this is the first time using these drugs, administer with another person present for assistance in case a serious allergic reaction occurs.</item>
<item>Always wash their hands before handling a bottle of otic drops and be mindful of the bottle cap to ensure that it remains as germ-free as possible.</item>
<item>Roll the bottle of otic drops between their hands for a few moments to warm the drops. Instillation of cold drops can cause dizziness.</item>
<item>Administer the drops with the pinna in an upward position; it should remain up during otic drop instillation.</item>
<item>Keep the ear facing up for about 5 minutes for the drop(s) to bathe the ear canal and minimize the amount of medication leakage (Mayo Clinic, 2023).</item>
<item>Use a latex-free dropper if they have a latex allergy.</item>
</list>
<para id="para-00007"><emphasis effect="bold">The client taking an otic anti-inflammatory <emphasis effect="italics">should not:</emphasis></emphasis></para>
<list list-type="bulleted" id="list-00005">
<item>Heat the drops above body temperature because administering drops that are too warm can damage the ear canal.</item>
<item>Drive or operate machinery until any occurrences of dizziness and vertigo have subsided.</item>
<item>Use cotton swabs in their ears due to the risk of perforation and further irritation and injury (Cleveland Clinic, 2022a).</item>
<item>Use the medication for longer than the prescribed duration.</item>
</list>
</note>
</section>
</section>
<section id="sect-00006">
<title>Otic Topical Anti-Infectives</title>
<para id="para-00008">Otic anti-infectives are indicated for clients who have otitis externa. Topical anti-infectives are prescribed to treat bacterial infections but are ineffective for viral infections. If the infection does not improve after 1 week of treatment, cultures and susceptibility tests should be repeated to verify the identity of the organism and to determine whether the therapy should be changed.</para>
<para id="para-00009"><link target-id="table-00002" document="m00466"/> lists common <term class="no-emphasis" id="term-00006">otic topical anti-infectives</term> and typical routes and dosing for adult and <term class="no-emphasis" id="term-00007">pediatric clients</term>.</para>
<table class="vertically-tight" id="table-00002">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="2*"/>
<thead>
<row>
<entry valign="top" align="center"><emphasis effect="bold"><span class="blue-text">Drug</span></emphasis></entry>
<entry valign="top" align="center"><emphasis effect="bold"><span class="blue-text">Routes and Dosage Ranges</span></emphasis></entry>
</row>
</thead>
<tbody>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00008">Ciprofloxacin&#160;0.3%<newline/>
and dexamethasone&#160;0.1%</term><newline/>
(<term class="no-emphasis" id="term-00009">Ciprodex</term>)</entry>
<entry valign="top" align="left"><emphasis effect="bold">For the treatment of acute otitis media in adults and acute otitis media in children with tympanostomy tubes:</emphasis><newline/>
4 drops instilled into the affected ear twice daily for 7 days.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00010">Ciprofloxacin&#160;0.2%<newline/>
and hydrocortisone&#160;1%</term><newline/>
(<term class="no-emphasis" id="term-00011">Cipro HC</term>)</entry>
<entry valign="top" align="left"><emphasis effect="bold">For the treatment of acute otitis externa due to susceptible organisms:</emphasis><newline/>
<emphasis effect="italics">For clients ≥1 year:</emphasis> 3 drops instilled into the affected ear(s) twice daily for 7 days. Maximum dose: 6 drops daily to affected ear(s).</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00012">Ofloxacin</term><newline/>
(<term class="no-emphasis" id="term-00013">Floxin</term>)</entry>
<entry valign="top" align="left"><emphasis effect="bold">For the treatment of otitis media and acute otitis media in children with tympanostomy tubes:</emphasis><newline/>
  <emphasis effect="italics">For clients 1&#8211;12 years:</emphasis> 5 drops (0.75 mg) in the affected ear(s) twice daily for 10 days.<newline/>
<emphasis effect="bold">For the treatment of long-term suppurative otitis media with perforated tympanic membranes:</emphasis><newline/>
<emphasis effect="italics">For clients 12 and older:</emphasis> 10 drops (1.5 mg) in the affected ear(s) twice daily for 14 days.<newline/>
<emphasis effect="bold">For the treatment of otitis externa due to <emphasis effect="italics">Escherichia coli</emphasis>, <emphasis effect="italics">Pseudomonas aeruginosa</emphasis>, and <emphasis effect="italics">Staphylococcus aureus</emphasis></emphasis><newline/>
<emphasis effect="italics">For clients 6 months &#8212;12 years:</emphasis> 5 drops (0.25 mL, 0.75 mg ofloxacin) in the affected ear(s) once daily for 7 days.<newline/>
<emphasis effect="italics">For clients 13 years and older:</emphasis> 10 drops (0.5 mL, 1.5 mg ofloxacin) in the affected ear(s) once daily for 7 days.</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Emphasis Table: Otic Topical Anti-infectives</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
<section id="sect-00007">
<title>Adverse Effects and Contraindications</title>
<para id="para-00010">Adverse effects of otic anti-infectives may include ear itching, fungal ear superinfection, earache, tinnitus, and transient hearing loss. Contraindications to taking otic anti-infectives include a history of hypersensitivity to any ingredient in the medication.</para>
<para id="para-00011"><link target-id="table-00003" document="m00466"/> is a drug prototype table for otic topical anti-infectives featuring ciprofloxacin 0.2%/hydrocortisone 1%. It lists drug class, mechanism of action, adult and <term class="no-emphasis" id="term-00014">pediatric dosage</term>, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
<table class="vertically-tight" id="table-00003">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Class</emphasis></span><newline/>
Otic topical anti-infective<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline/>
Kills bacteria<newline/>
Reduces inflammatory response that accompanies infection</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline/>
<emphasis effect="italics">For clients ≥1 year:</emphasis> 3 drops instilled into the affected ear(s) twice daily for 7 days. Maximum dose: 6 drops daily to affected ear(s).</entry>
</row>
<row>
<entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Indications</span></emphasis><newline/>
For the treatment of superficial bacterial infections of the external auditory canal (i.e., otitis externa) caused by susceptible organisms, including pseudomonas and staphylococcus<newline/>
For the treatment of infections of mastoidectomy<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline/>
Eases discomfort<newline/>
Reduces inflammation<newline/>
Treats infection
</entry>
<entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Drug Interactions</span></emphasis><newline/>
No significant interactions<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline/>
No significant interactions
</entry>
</row>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
Ear itching<newline/>
Fungal ear superinfection<newline/>
Earache<newline/>
Tinnitus<newline/>
Transient hearing loss<newline/>
Dizziness</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline/>
A history of hypersensitivity to ciprofloxacin
</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Prototype Table: Ciprofloxacin 0.2% and Hydrocortisone 1%</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
</section>
<section id="sect-00008">
<title>Nursing Implications</title>
<para id="para-00012">The nurse should do the following for clients who are taking otic anti-infectives:</para>
<list list-type="bulleted" id="list-00006">
<item>Recognize and monitor for serious and potential side effects, primarily a rash or any evidence of hypersensitivity to quinolones. Anaphylaxis can occur. Clients with latex allergies need to use a latex-free dropper to administer.</item>
<item>Perform hand hygiene before administering.</item>
<item>Educate the client on ear position and time to remain in a lying position after instillation.</item>
<item>Monitor complete blood count, if ordered, for decreased eosinophils.</item>
<item>Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.</item>
</list>
<note class="client-teaching" id="note-00002">
<para id="para-00013"><emphasis effect="bold">The client taking an otic topical anti-infective should:</emphasis></para>
<list list-type="bulleted" id="list-00007">
<item>Report ear pain or worsening of itching to the health care provider; they may need an ear swab to test for superinfection if used for an extended period.</item>
<item>Always wash their hands before handling a bottle of otic drops and be mindful of the bottle cap to ensure that it remains as germ-free as possible.</item>
<item>Roll the bottle of otic drops between hands for a few moments to warm the drops. Instillation of cold drops can cause dizziness.</item>
<item>Administer the drops with the pinna in an upward position; it should remain up during otic drop instillation.</item>
<item>Keep the ear facing up for about 5 minutes for the drop(s) to bathe the ear canal and minimize the amount of medication leakage (Mayo Clinic, 2023).</item>
</list>
<para id="para-00014"><emphasis effect="bold">The client taking an otic topical anti-infective <emphasis effect="italics">should not:</emphasis></emphasis></para>
<list list-type="bulleted" id="list-00008">
<item>Warm the drops to greater than their body temperature because this can damage the ear.</item>
<item>Drive or operate machinery until any occurrences of dizziness have subsided.</item>
<item>Use cotton swabs in their ears due to the risk of perforation and further irritation and injury (Cleveland Clinic, 2022a).</item>
</list>
</note>
<note class="clinical-tip" id="note-00003">
<title>Topical Otic Medication Administration</title>
<media alt="atoms_isotopes">
<iframe width="560" height="315" src="https://openstax.org/r/administering"/>
</media>
<para id="para-00016">This video from Tacoma Community College demonstrates the proper procedure for administering otic medication to an adult client.</para>
<para id="para-00017">For a <term class="no-emphasis" id="term-00015">pediatric client</term>, review these <link url="https://openstax.org/r/healthychildren">instructions from the American Academy of Pediatrics</link>.</para>
</note>
</section>
</section>
<section id="sect-00009">
<title>Systemic Anti-Infectives for Infections of the Ear</title>
<para id="para-00018">Systemic otic anti-infectives are indicated for clients who have otitis media. Acute otitis media in adults can cause significant complications; therefore, most adults are treated with antibiotic therapy (Limb et al., 2023). Antibiotic therapy is used more judiciously in <term class="no-emphasis" id="term-00016">children</term> to avoid antibiotic resistance and side effects. High-dose amoxicillin is the first-line choice for both children and adults (Danishyar &amp; Ashurst, 2023). If high-dose amoxicillin is not effective, high-dose amoxicillin-clavulanate is the second-line treatment. For clients with penicillin allergies or non-responders, azithromycin or cefdinir are two alternatives that can be considered.</para>
<para id="para-00019"><link target-id="table-00004" document="m00466"/> lists common <term class="no-emphasis" id="term-00017">otic systemic anti-infectives</term> and typical routes and dosing for adult and <term class="no-emphasis" id="term-00018">pediatric clients</term>.</para>
<table class="vertically-tight" id="table-00004">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="2*"/>
<thead>
<row>
<entry valign="top" align="center"><emphasis effect="bold"><span class="blue-text">Drug</span></emphasis></entry>
<entry valign="top" align="center"><emphasis effect="bold"><span class="blue-text">Routes and Dosage Ranges</span></emphasis></entry>
</row>
</thead>
<tbody>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00019">Amoxicillin</term><newline/>
(<term class="no-emphasis" id="term-00020">Amoxil</term>, <term class="no-emphasis" id="term-00021">Trimox</term>)</entry>
<entry valign="top" align="left"><emphasis effect="bold">Severe infections:</emphasis><newline/>
<emphasis effect="italics">Adults:</emphasis> 875 mg orally every 12 hours or 500 mg orally every 8 hours.<newline/>
<emphasis effect="italics">Children &lt;3 months:</emphasis> Amoxicillin 30 mg/kg daily for a 10-day course, given in 2 divided doses.<newline/>
<emphasis effect="italics">Children > 3 months:</emphasis> Amoxicillin 45 mg/kg daily for a 7-day course, given in 2 divided doses.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00022">Amoxicillin-clavulanate</term><newline/>
(<term class="no-emphasis" id="term-00023">Augmentin</term>)</entry>
<entry valign="top" align="left"><emphasis effect="bold">Severe infections:</emphasis><newline/>
<emphasis effect="italics">Adults:</emphasis> 1 875 mg amoxicillin/125 mg potassium clavulanate tablet orally every 12 hours or 1 500 mg amoxicillin/125 mg potassium clavulanate tablet orally every 8 hours.<newline/>
<emphasis effect="italics">Children >40 kg:</emphasis> Use adult dosing.<newline/>
<emphasis effect="italics">Children >3 months and weighing &lt;40 kg:</emphasis> 45 mg/kg daily orally every 12 hours or 40 mg/kg daily every 8 hours (using 200 mg amoxicillin/28.5 mg potassium clavulanate mg per 5 mL or 400 mg amoxicillin/57 mg potassium clavulanate per 5 mL oral suspension).<newline/>
<emphasis effect="italics">Children &lt;3 months:</emphasis> 30 mg/kg daily orally every 12 hours (using 125 mg amoxicillin/31.25 mg potassium clavulanate mg per 5 mL oral suspension).</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00024">Azithromycin</term><newline/>
(<term class="no-emphasis" id="term-00025">Zithromax</term>)</entry>
<entry valign="top" align="left"><emphasis effect="bold">For children with acute otitis media (using oral suspension 500 mg in 5 mL):</emphasis><newline/>
<emphasis effect="italics">Children >6 months:</emphasis> 30 mg/kg orally as a single dose, or 10 mg/kg once daily for 3 days, or 10 mg/kg as a single dose on day 1 followed by 5 mg/kg daily on days 2 through 5.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00026">Cefdinir</term><newline/>
(<term class="no-emphasis" id="term-00027">Omnicef</term>)</entry>
<entry valign="top" align="left"><emphasis effect="bold">For children with acute otitis media (using either 125 mg per 5 mL or 250 mg per 5 mL oral suspension):</emphasis><newline/>
<emphasis effect="italics">Children 6 months through 12 years:</emphasis> 7 mg/kg orally every 12 hours for 5–10 days or 14 mg/kg orally every 24 hours for 10 days.</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Emphasis Table: Otic Systemic Anti-infectives</emphasis> (sources: https://dailymed.nlm.nih.gov/dailymed/; Bode, 2020)</caption>
</table>
<section id="sect-00010">
<title>Adverse Effects and Contraindications</title>
<para id="para-00020">Systemic antibiotics can lead to diarrhea and possibly pseudomembranous colitis and <emphasis effect="italics">Clostridium difficile</emphasis> infection. Symptoms of <emphasis effect="italics">C. difficile</emphasis> can range from mild to life-threatening and may require hospitalization and extended therapy. Antibiotic-related diarrhea can occur up to 2 months after ceasing antibiotic therapy. Antibiotics can cause allergic reactions, especially in clients with other sensitivities.</para>
<para id="para-00021"><link target-id="table-00005" document="m00466"/> is a drug prototype table for otic systemic anti-infectives featuring amoxicillin. It lists drug class, mechanism of action, adult and <term class="no-emphasis" id="term-00028">pediatric dosage</term>, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
<table class="vertically-tight" id="table-00005">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Class</emphasis></span><newline/>
Systemic anti-infective; analog of ampicillin<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline/>
Bactericidal antibiotic effective for many gram-positive and gram-negative bacteria
</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline/>
<emphasis effect="bold">Severe infections:</emphasis><newline/>
<emphasis effect="italics">Adults:</emphasis> 875 mg orally every 12 hours or 500 mg orally every 8 hours.<newline/>
<emphasis effect="italics">Children &lt;3 months:</emphasis> Amoxicillin 30 mg/kg/day for a 10-day course, given in 2 divided doses.<newline/>
<emphasis effect="italics">Children >3 months:</emphasis> Amoxicillin 45 mg/kg/day for a 7-day course, given in 2 divided doses.</entry>
</row>
<row>
<entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Indications</span></emphasis><newline/>
For the treatment of acute otitis media and sinusitis<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline/>
Treats infection</entry>
<entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Drug Interactions</span></emphasis><newline/>
Probenecid<newline/>
Oral estrogen/progesterone contraceptives<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline/>
No significant interactions</entry>
</row>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
Sensitivity reactions, particularly in clients allergic to penicillin<newline/>
Diarrhea including from <emphasis effect="italics">Clostridium difficile</emphasis><newline/>
Abnormal liver function tests</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline/>
Known hypersensitivity to penicillin
</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Prototype Table: Amoxicillin</emphasis> (sources: https://dailymed.nlm.nih.gov/dailymed/; Bode, 2020)</caption>
</table>
</section>
<section id="sect-00011">
<title>Nursing Implications</title>
<para id="para-00022">The nurse should do the following for clients who are taking systemic anti-infectives for otic conditions:</para>
<list list-type="bulleted" id="list-00009">
<item>Recognize and monitor for serious and potential side effects including signs of allergic reactions and new onset of diarrhea.</item>
<item>Follow dosing instructions carefully, particularly with amoxicillin-clavulanate (Augmentin). Different forms of Augmentin contain different amounts of amoxicillin but the same amounts of clavulanic acid, so the strengths are not interchangeable. For example, two 250 mg Augmentin tablets are not the equivalent of a 500 mg tablet. If a client is prescribed 500 mg, the client must take the 500 mg tablet, not two 250 mg tablets.</item>
<item>Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.</item>
</list>
<note class="client-teaching" id="note-00004">
<para id="para-00023"><emphasis effect="bold">The client taking an otic systemic anti-infective should:</emphasis></para>
<list list-type="bulleted" id="list-00010">
<item>Report episodes of diarrhea to their health care provider.</item>
<item>Take all their antibiotic(s) as prescribed.</item>
<item>Keep follow-up appointments.</item>
</list>
<para id="para-00024"><emphasis effect="bold">The client an otic systemic anti-infective <emphasis effect="italics">should not:</emphasis></emphasis></para>
<list list-type="bulleted" id="list-00011">
<item>Share antibiotics with others.</item>
</list>
</note>
</section>
</section>
</content>
</document>